Cited by 42Retinal Diseases and TreatmentsRetinal and Macular SurgeryOcular Diseases and Behçet’s Syndrome

Prophylactic laser treatment hastens choroidal neovascularization in unilateral age-related maculopathy: final results of the drusen laser study

Owens, Sarah L., Bunce, Catey, Brannon, Alan J., Xing, Wen, Chisholm, Iain H., Gross, Mirjam, Guymer, Robyn H., Holz, Frank G. +1 more·2006·American Journal of Ophthalmology

Abstract

Purpose The Drusen Laser Study evaluated macular laser to prevent choroidal neovascularization (CNV) and vision loss in high-risk age-related maculopathy (ARM).Design Prospective, interventional, randomized, controlled clinical trial in five hospital centers.Methods Patients in the unilateral group had neovascular ARM and drusen in the study eye. Study eyes were randomized to laser-treated or no-laser groups. For patients in the bilateral drusen group, eyes were randomized to right eye, laser or no laser; and left eye, alternative. Laser treatment comprised 12 argon spots. Outcome was best-corrected visual acuity and CNV signs, which were monitored for 3 years.Results In the unilateral group, vision loss occurred in 21 (28.8%) of 73 patients in laser vs 13 (19.7%) of 66 no-laser patients (P=.214). Incidence of CNV was 27 (29.7%) of 91 in laser vs 15 (17.65%) of 85 no-laser patients (P=.061). CNV onset was approximately 6 months earlier in laser-treated compared with no-laser patients (P=.05). In the bilateral group, vision loss occurred in six (8.3%) of 72 laser-treated vs 10 (13.9%) of 72 fellow eyes (P=.3877). CNV incidence was 12 (11.6%) of 103 in laser-treated vs seven (6.8%) of 103 fellow eyes (P=.225). There was no difference in onset of CNV.Conclusions Results do not support prophylactic laser of the fellow eye of patients with neovascular ARM. Its role in patients with bilateral drusen remains unclear.

Integrity signals

Registry

Crossref · 10.1016/j.ajo.2005.08.019

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Laser treatment did seem to delay the development of choroidal neovascularisation by 6 months in studies that included patients with unilateral advanced age-related macular degeneration.

    “Laser treatment did seem to delay the development of choroidal neovascularisation by 6 months in studies that included patients with unilateral advanced age-related macular degeneration.157,158”

    From Age-related macular degeneration (2008) · cites this paper as [157]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Owens, S. L., Bunce, C., Brannon, A. J., Xing, W., Chisholm, I. H., Gross, M., Guymer, R. H., Holz, F. G., & Bird, A. C.
Affiliations
  • Moorfields Eye Hospital NHS Foundation Trust (GB)
  • Moorfields Eye Hospital (GB)
  • The University of Melbourne (AU)
  • Heidelberg University (DE)
Corresponding author
Owens, Sarah L.
Venue
American Journal of Ophthalmology
Publisher
Elsevier BV
Published
2006-02
Volume
141
Issue
2
Pages
276-281
ISSN
0002-9394 (ISSN-L)
OpenAlex
W1983972989
Cited by
42
References
20
Citations by year
2022: 1 · 2021: 3 · 2020: 4 · 2019: 2 · 2018: 6 · 2017: 2 · 2016: 1 · 2015: 1 · 2014: 1 · 2012: 3
FWCI
4.27
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Ophthalmology (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal and Macular Surgery
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords
choroidal neovascularization, age-related maculopathy, drusen, argon laser, blindness prevention, best-corrected visual acuity, fellow eye
MeSH terms
Aged, Aged, 80 and over, Female, Humans, Functional Laterality, Macular Degeneration, Male, Middle Aged, Prospective Studies, Visual Acuity, Retinal Drusen, Incidence, Laser Coagulation, Choroidal Neovascularization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review